We are proud to present the 12th Annual
Pre-Filled Syringes and Injectable Drug Devices Conference in London on 15th and 16th January 2020.
As Europe's leading
PFS conference and given the key factors driving the market, we will assess innovations in design controls and applications, enhancement of human factors and optimizing formulation and containment.
The rapid expansion of the
PFS market and the regulatory environment are more important than ever, this year's programme will look at the EU MDR, Article 117, ISO change management standard as well as insights into the MDR post-market safety report, providing a holistic review of the
Pre-Filled Syringes industry.
This two-day agenda offers you peer-to-peer networking with Global Product Managers, Senior PFS Engineers, Device Testing Managers, Heads of Late-Stage PFS Development and many more.
We look forward to welcoming you to the conference in January.
This is our most sought-after event and will be sold out soon. Early registration is strongly advised to avoid disappointment.
Benefits of Attending
- EXPLORE design controls, life cycle management and risk management strategies for PFS
- UNDERSTAND the current regulatory environment of PFS from leading advisors
- DELVE into formulation and container interaction considerations and best practices
- LEARN from industry experts in an interactive pre-conference workshop day
Who should attend
- Drug-delivery developers
- Medical Device Engineers
- Primary Packaging material designers
- Secondary packagers
- Smart device developers
- Training device developers
- Device-safety solution providers
- Drug developers
Plus a Pre-Conference Workshop Day | Tuesday 14th January 2019
Workshop A:
A Roadmap to Regulation Quality Management Systems and Technical StandardsWorkshop Leader: Amanda Matthews, Senior Director - Combination Products & Medical Devices, Global Regulatory Affairs, fizer
08.30 - 12.00
Workshop B:
Testing requirements on Pre-Filled SyringesWorkshop Leader: Horst Koller, CEO, HK Packaging Consulting
13.00 - 15.30
Workshop C:
Extractables and leachables: Considerations for PFS PlatformsWorkshop Leaders: Carsten Worsoe, Principal Scientist, Novo Nordisk
Raphael Nudelman, Director of Chemical and Computational Toxicology, Teva Pharmaceuticals
16.00 - 18.20
Speakers
- Abha Raveau-Violette, Device Manager, AstraZeneca
- Alison Bascou, Senior Manager Regulatory Affairs, Beckton Dickinson (BD)
- Amanda Matthews, Senior Director, Pfizer UK Limited
- Anil-Kumar Busimi, Strategy and Innovation, Senior Global Product Manager, iQ Platform, SCHOTT Pharmceutical Systems
- Benjamin Werner, Scientist, Boehringer Ingelheim Pharma GmbH & Co. KG
- Carsten Worsoe, Principal Scientist, Novo Nordisk
- Cedric Gysel, Healthcare Solutions Manager, Johnson & Johnson
- Christa Jansen-Otten, Director Global Product Management, Prefilled Systems & Delivery, West Pharmaceutical Services
- Cinzia Rotella, Senior Materials Scientist, Sanofi
- Clemens Guenther, Director Nonclinical Safety Consumer Care, Bayer
- Colin Roscoe, Principal Human Factors Scientist, Teva Pharmaceuticals
- Hiroki Hasegawa, Researcher, Mitsubishi Gas Chemical Company, Inc
- Horst Koller, CEO, HK Packaging Consulting GmbH
- James Mellman, Device Manager, Novartis A G
- Jochen Heinz, Director New Products and Technology, Transcoject GmbH
- Kewei Yang, Pharmaceutical Scientist, Roche
- Khaudeja Bano, Head of Medical Devices, Abbott Molecular Inc
- Lise Vanderkelen, Department Head, Nelson Labs NV
- Marion Westwood, Pharmaceutical Assesor, Medicines & Healthcare products Regulatory Agency (MHRA)
- Matthew Nicolas, Investigator, GlaxoSmithKline
- Nicolas Brandes, Director Global Product Management Polymer Prefilled Systems and Vial Containment, West Pharmaceutical Services
- Nicolas Eon, Senior Global Product Manager, SCHOTT Pharmceutical Systems
- Olaf Lebau, Design Engineer for Medical Devices and Combination Products, Boehringer Ingelheim GmbH
- Orfeo Niedermann, Business Development Director, Ypsomed
- Raphael Nudelman, Director of Chemical and Computational Toxicology, Teva Pharmaceuticals Industries
- Reinhard Scheller, Commercial Manager COP Europe, Zeon Europe GmbH
- Remy Vomscheid, Director, Devices Development & Technologies, IPSEN Pharmsciences
- Severine Duband, Global Category Manager, Nemera
- Torsten Kneuss, Quality Assurance Manager Combination Products, Bayer Pharma
- Ubaldo Martin, Inflammation Neuroscience and Respiratory GMED, AstraZeneca
Please fill in your name and email to receive the Conference Agenda of this event.
Venue
Copthorne Tara Hotel
Scarsdale Pl, Kensington, W8 5SY
London, UK
